The state of California banned the Red No. 3 dye and three other food additives in 2023, which gave manufacturers until 2027 ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC ...

Pro-choice lawmakers, doctors and advocates have argued the science is settled when it comes to the controversial abortion pill mifepristone. They say the drug is safe and that it needs to be widely ...

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., Appeal Nos. 2024-1965, -1966, -2082, -2083 (Fed. Cir. Jan. 29, 2025) ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

Pro-choice advocates say the science is settled on the abortion pill mifepristone, but critics argue that better safeguards ...

Most states allow some sale of cannabis, but testing for pesticides and mold in the weed supply varies from one state to another.

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

USE ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson’s disease (PD). It is not known if ONAPGO is safe and effective in children.